Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $145.2200 (-1.08%) ($145.2200 - $145.2200) on Thu. Apr. 29, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.22% (three month average) | RSI | 41 | Latest Price | $145.2200(-1.08%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -0.4% a day on average for past five trading days. | Weekly Trend | LGND declines -0.3% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(58%) IWO(57%) IWM(54%) IWC(52%) XBI(51%) | Factors Impacting LGND price | LGND will decline at least -2.11% in a week (0% probabilities). VIXM(-27%) VXX(-17%) UUP(-17%) UNG(-3%) IGOV(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.11% (StdDev 4.22%) | Hourly BBV | -1.3 () | Intraday Trend | 0% | | | |
|
Resistance Level | $149.83 | 5 Day Moving Average | $148.26(-2.05%) | 10 Day Moving Average | $148.35(-2.11%) | 20 Day Moving Average | $149.83(-3.08%) | To recent high | -32.7% | To recent low | 4.5% | Market Cap | $2.334b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |